Clinical Trials Browser

Phase 2 × Suspended × Gemcitabine × Clear all

NCT07283705 2026-03-18

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Phase 2 Suspended

Gastrointestinal

Phase 2 Study

NCT00536770 2007-11-06

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Phase 2 Suspended

Gastrointestinal

Pancreatic Neoplasms